X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS IPCA LABS DR. DATSONS LABS/
IPCA LABS
 
P/E (TTM) x -10.9 29.4 - View Chart
P/BV x 0.2 3.7 4.3% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 DR. DATSONS LABS   IPCA LABS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
IPCA LABS
Mar-18
DR. DATSONS LABS/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs126695 18.1%   
Low Rs31400 7.7%   
Sales per share (Unadj.) Rs133.0260.2 51.1%  
Earnings per share (Unadj.) Rs0.219.0 0.8%  
Cash flow per share (Unadj.) Rs6.633.1 20.0%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs128.8213.0 60.5%  
Shares outstanding (eoy) m31.66126.20 25.1%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.62.1 28.0%   
Avg P/E ratio x516.128.9 1,787.8%  
P/CF ratio (eoy) x11.816.6 71.5%  
Price / Book Value ratio x0.62.6 23.6%  
Dividend payout %05.3 0.0%   
Avg Mkt Cap Rs m2,47769,120 3.6%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m567,359 0.8%   
Avg. sales/employee Rs ThNM2,477.4-  
Avg. wages/employee Rs ThNM555.2-  
Avg. net profit/employee Rs ThNM180.6-  
INCOME DATA
Net Sales Rs m4,21132,836 12.8%  
Other income Rs m79418 18.8%   
Total revenues Rs m4,28933,254 12.9%   
Gross profit Rs m5694,505 12.6%  
Depreciation Rs m2041,777 11.5%   
Interest Rs m430240 179.1%   
Profit before tax Rs m132,905 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6511 1.2%   
Profit after tax Rs m52,394 0.2%  
Gross profit margin %13.513.7 98.4%  
Effective tax rate %48.017.6 273.0%   
Net profit margin %0.17.3 1.6%  
BALANCE SHEET DATA
Current assets Rs m6,85219,455 35.2%   
Current liabilities Rs m6,71110,076 66.6%   
Net working cap to sales %3.328.6 11.7%  
Current ratio x1.01.9 52.9%  
Inventory Days Days16198 164.3%  
Debtors Days Days31867 475.7%  
Net fixed assets Rs m3,67320,260 18.1%   
Share capital Rs m317252 125.4%   
"Free" reserves Rs m3,76126,633 14.1%   
Net worth Rs m4,07826,886 15.2%   
Long term debt Rs m1,6712,340 71.4%   
Total assets Rs m12,63341,173 30.7%  
Interest coverage x1.013.1 7.9%   
Debt to equity ratio x0.40.1 470.8%  
Sales to assets ratio x0.30.8 41.8%   
Return on assets %3.46.4 53.8%  
Return on equity %0.18.9 1.3%  
Return on capital %7.710.8 71.3%  
Exports to sales %22.947.6 48.1%   
Imports to sales %14.314.9 96.1%   
Exports (fob) Rs m96415,642 6.2%   
Imports (cif) Rs m6024,884 12.3%   
Fx inflow Rs m96415,642 6.2%   
Fx outflow Rs m6074,884 12.4%   
Net fx Rs m35710,759 3.3%   
CASH FLOW
From Operations Rs m1,3453,411 39.4%  
From Investments Rs m-2,256-1,354 166.6%  
From Financial Activity Rs m-1,200-1,304 92.0%  
Net Cashflow Rs m-2,111753 -280.2%  

Share Holding

Indian Promoters % 4.5 45.9 9.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.4 -  
FIIs % 1.4 25.3 5.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.4 540.8%  
Shareholders   20,807 36,892 56.4%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   TORRENT PHARMA  NATCO PHARMA  AJANTA PHARMA  PFIZER  ALKEM LABORATORIES  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 307 Points Higher; Metal and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets traded on a positive note throughout the day and ended on a strong note. Gains were seen in the metal sector.

Related Views on News

IPCA LABS Announces Quarterly Results (2QFY19); Net Profit Up 24.1% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, IPCA LABS has posted a net profit of Rs 1 bn (up 24.1% YoY). Sales on the other hand came in at Rs 10 bn (up 15.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY19); Net Profit Down 423.6% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, IPCA LABS has posted a net profit of Rs 655 m (down 423.6% YoY). Sales on the other hand came in at Rs 9 bn (up 19.8% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Patel's Exit, Election Results, and 4 'Must Have' Small Caps in These Exceptional Times(Profit Hunter)

Dec 11, 2018

RBI Governor's resignation is a statement of dissent with the way government is handling the economy's affairs and could lead to some serious market correction. Here's how to make the most of it.

Players in an Oligopoly Should Have Financials Like This(Chart Of The Day)

Dec 7, 2018

This stock has corrected 30% from peak and looks attractive at these valuations.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS